Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 7
2005 8
2006 8
2007 5
2008 10
2009 4
2010 11
2011 14
2012 16
2013 13
2014 21
2015 6
2016 15
2017 17
2018 15
2019 11
2020 15
2021 20
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Results by year
Filters applied: . Clear all
Page 1
Nanobodies: natural single-domain antibodies.
Muyldermans S. Muyldermans S. Annu Rev Biochem. 2013;82:775-97. doi: 10.1146/annurev-biochem-063011-092449. Epub 2013 Mar 13. Annu Rev Biochem. 2013. PMID: 23495938 Review.
Applications of Nanobodies.
Muyldermans S. Muyldermans S. Annu Rev Anim Biosci. 2021 Feb 16;9:401-421. doi: 10.1146/annurev-animal-021419-083831. Epub 2020 Nov 24. Annu Rev Anim Biosci. 2021. PMID: 33233943 Review.
The Therapeutic Potential of Nanobodies.
Jovčevska I, Muyldermans S. Jovčevska I, et al. Among authors: muyldermans s. BioDrugs. 2020 Feb;34(1):11-26. doi: 10.1007/s40259-019-00392-z. BioDrugs. 2020. PMID: 31686399 Free PMC article. Review.
A guide to: generation and design of nanobodies.
Muyldermans S. Muyldermans S. FEBS J. 2021 Apr;288(7):2084-2102. doi: 10.1111/febs.15515. Epub 2020 Aug 28. FEBS J. 2021. PMID: 32780549 Free PMC article. Review.
A general protocol for the generation of Nanobodies for structural biology.
Pardon E, Laeremans T, Triest S, Rasmussen SG, Wohlkönig A, Ruf A, Muyldermans S, Hol WG, Kobilka BK, Steyaert J. Pardon E, et al. Among authors: muyldermans s. Nat Protoc. 2014 Mar;9(3):674-93. doi: 10.1038/nprot.2014.039. Epub 2014 Feb 27. Nat Protoc. 2014. PMID: 24577359 Free PMC article.
Modulation of protein properties in living cells using nanobodies.
Kirchhofer A, Helma J, Schmidthals K, Frauer C, Cui S, Karcher A, Pellis M, Muyldermans S, Casas-Delucchi CS, Cardoso MC, Leonhardt H, Hopfner KP, Rothbauer U. Kirchhofer A, et al. Among authors: muyldermans s. Nat Struct Mol Biol. 2010 Jan;17(1):133-8. doi: 10.1038/nsmb.1727. Epub 2009 Dec 13. Nat Struct Mol Biol. 2010. PMID: 20010839
Non-canonical roles of connexins.
Van Campenhout R, Cooreman A, Leroy K, Rusiecka OM, Van Brantegem P, Annaert P, Muyldermans S, Devoogdt N, Cogliati B, Kwak BR, Vinken M. Van Campenhout R, et al. Among authors: muyldermans s. Prog Biophys Mol Biol. 2020 Jul;153:35-41. doi: 10.1016/j.pbiomolbio.2020.03.002. Epub 2020 Mar 24. Prog Biophys Mol Biol. 2020. PMID: 32220599 Review.
Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.
Sparkes A, De Baetselier P, Brys L, Cabrito I, Sterckx YG, Schoonooghe S, Muyldermans S, Raes G, Bucala R, Vanlandschoot P, Van Ginderachter JA, Stijlemans B. Sparkes A, et al. Among authors: muyldermans s. FASEB J. 2018 Jun;32(6):3411-3422. doi: 10.1096/fj.201701189R. Epub 2018 Jan 25. FASEB J. 2018. PMID: 29401625 Free PMC article.
Immunogenicity Risk Profile of Nanobodies.
Ackaert C, Smiejkowska N, Xavier C, Sterckx YGJ, Denies S, Stijlemans B, Elkrim Y, Devoogdt N, Caveliers V, Lahoutte T, Muyldermans S, Breckpot K, Keyaerts M. Ackaert C, et al. Among authors: muyldermans s. Front Immunol. 2021 Mar 9;12:632687. doi: 10.3389/fimmu.2021.632687. eCollection 2021. Front Immunol. 2021. PMID: 33767701 Free PMC article.
208 results